Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

NICE (UK) recommends Ontozry (cenobamate) for treating focal onset seizures in epilepsy – Arvelle Therapeutics

Written by | 13 Jun 2025

NICE(UK): Cenobamate is recommended as an option as an add-on treatment for focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has… read more.

CHMP recommends approval of Ontozry for focal – onset (partial-onset) seizures – SK Biopharmaceuticals

Written by | 12 Feb 2021

SK Biopharmaceuticals announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.